Results 131 to 140 of about 4,803,785 (352)

Science 3.0: Corrections to the Science 2.0 paradigm [PDF]

, 2013
The concept of Science 2.0 was introduced almost a decade ago to describe the new generation of online-based tools for researchers allowing easier data sharing, collaboration and publishing.
Teif, Vladimir B.
core   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

To be indexed

South African Family Practice, 2006
No abstract available.
Pierre J.T. de Villiers
doaj   +1 more source

The Ore Deposits of the United States and Canada . By James Furman Kemp. Third Edition entirely rewritten and enlarged. New York and London, The Scientific Publishing Company. 1900. [PDF]

, 1900
Samuel Franklin Emmons
openalex   +1 more source

Temporal signatures of the Cherenkov light induced by extensive air showers of cosmic rays detected with the Yakutsk array

, 2016
We analyze temporal characteristics of signals from the wide field-of-view (WFOV) Cherenkov telescope (CT) detecting extensive air showers (EAS) of cosmic rays (CR) in coincidence with surface detectors of the Yakutsk array.
Ivanov, A. A., Timofeev, L. V.
core   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Gauge Invariance in 2PI Effective Actions

, 2003
The problem of maintaining gauge invariance in the 2PI formulation of QED is discussed. A modified form of the 2PI effective action is suggested in which Ward identities for external (background field) and internal (quantum field) gauge transformations ...
Mottola, Emil
core   +1 more source

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

Molecular Oncology, EarlyView.
Cyclin D1 overexpression altered the cell adhesion pathway, while cyclin D2 upregulation had less impact on pathway enrichment analysis. Multiple myeloma (MM) patients with cyclin D1 overexpression showed reduced CD56 expression and increased circulating tumor cells (CTC) levels, suggesting that cyclin D1 may contribute to MM cell dissemination ...
Ignacio J. Cardona‐Benavides, Sara Cristobal‐Vargas, Cristina De Ramón, Elizabeta A. Rojas, Irena Misiewicz‐Krzeminska, Isabel Isidro, José Juan Pérez, Bruno Paiva, Noemi Puig, Miguel Alcoceba, María‐Victoria Mateos, Luis A. Corchete, Myriam Cuadrado, Norma C. Gutiérrez   +13 more
wiley   +1 more source

Marcel Florkin, A history of biochemistry. Part III. History of the identification of the sources of free energy in organisms, Amsterdam, Elsevier Scientific Publishing Co., 1975, 8vo, pp. [xxi], 475, illus., Dfl. 130.00. ($54.25). [PDF]

, 1976

openalex   +1 more source